Clinical Trial

Psoriasis Comorbidities at Hospital Calderón Guardia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to characterize the epidemiologic, clinical, severity, and therapeutic features of patients with psoriasis treated in Costa Rica between 2024 and 2025. The main questions it aims to answer are: What are the demographic and clinical characteristics and severity profiles of psoriasis patients? What treatments are used in routine clinical practice, and how are they associated with disease severity and outcomes? Patients with psoriasis receiving dermatologic care during the study period will be included. Data will be obtained retrospectively from electronic medical records and clinical registries without intervention or modification of treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-02.
Trial Details
NCT Number NCT07448337
Lead Sponsor Caja Costarricense de Seguro Social
Conditions Psoriasis, Psoriasis Arthritis, Psoriasis (PsO), Psoriasis Patients
Enrollment 350 participants
Start Date 2026-05
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-08